Simplex Trading
DNA icon

Simplex Trading’s Ginkgo Bioworks DNA Stock Holding History

Simplex Trading’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$164K Buy
16,500
+12,500
+313% +$105K ﹤0.01% 4963
2026
Q1 		$24.5K Buy
+4,000
New +$33.3K ﹤0.01% 6597
2025
Q4 		– Sell
-610,000
Closed -$8.89M – 8877
2025
Q3 		$8.89M Sell
610,000
-207,800
-25% -$2.49M ﹤0.01% 1045
2025
Q2 		$9.2M Buy
817,800
+242,300
+42% +$1.88M 0.01% 943
2025
Q1 		$3.28M Sell
575,500
-356,500
-38% -$3.63M ﹤0.01% 1591
2024
Q4 		$9.15M Sell
932,000
-193,600
-17% -$1.66M 0.01% 1085
2024
Q3 		$9.17M Buy
1,125,600
+1,104,112
+5,138% +$11.1M 0.01% 1088
2024
Q2 		$287K Buy
21,488
+10,243
+91% +$306K ﹤0.01% 4290
2024
Q1 		$521K Sell
11,245
-1,828
-14% -$94.6K ﹤0.01% 3821
2023
Q4 		$868K Buy
13,073
+2,058
+19% +$126K ﹤0.01% 3139
2023
Q3 		$797K Buy
11,015
+1,612
+17% +$129K ﹤0.01% 2899
2023
Q2 		$699K Sell
9,403
-1,107
-11% -$65.5K ﹤0.01% 2959
2023
Q1 		$559K Sell
10,510
-6,515
-38% -$413K ﹤0.01% 3147
2022
Q4 		$1.15M Sell
17,025
-5,340
-24% -$491K ﹤0.01% 2334
2022
Q3 		$2.79M Buy
22,365
+18,397
+464% +$2.19M ﹤0.01% 1678
2022
Q2 		$377K Sell
3,968
-1,992
-33% -$243K ﹤0.01% 3809
2022
Q1 		$960K Sell
5,960
-1,028
-15% -$200K ﹤0.01% 2969
2021
Q4 		$2.32M Buy
+6,988
New +$3.32M ﹤0.01% 1888

Other funds holding DNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return

Simplex Trading's DNA Position: Q2 2026 in Review

Simplex Trading increased its Ginkgo Bioworks (DNA) stake by 141% in Q2 2026, buying an estimated $88K and bringing the position to 17,995 shares worth $178K. The position accounts for ﹤0.01% of the portfolio, ranked #4859.

Simplex Trading first reported a position in DNA in Q1 2022 and has held it in 15 quarters since. The position peaked at $990K in Q1 2022. 184 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

  • Simplex Trading held 17,995 shares of Ginkgo Bioworks worth $178K as of Q2 2026.
  • Simplex Trading bought 10,521 Ginkgo Bioworks shares in Q2 2026, an estimated $88K.
  • Ginkgo Bioworks made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #4859 holding.
  • Simplex Trading first reported a position in Ginkgo Bioworks in Q1 2022 and has held it in 15 quarters since.
  • Simplex Trading's Ginkgo Bioworks position peaked at $990K in Q1 2022.
  • 184 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.